Olli Lohi

3.5k total citations · 1 hit paper
85 papers, 1.8k citations indexed

About

Olli Lohi is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Olli Lohi has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 24 papers in Public Health, Environmental and Occupational Health and 14 papers in Hematology. Recurrent topics in Olli Lohi's work include Acute Lymphoblastic Leukemia research (24 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Genomics and Chromatin Dynamics (8 papers). Olli Lohi is often cited by papers focused on Acute Lymphoblastic Leukemia research (24 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Genomics and Chromatin Dynamics (8 papers). Olli Lohi collaborates with scholars based in Finland, Sweden and United States. Olli Lohi's co-authors include Veli‐Pekka Lehto, Markku Mäki, Katri Kaukinen, Pekka Collin, E. Bravi, Maurizio Gasparin, Harri Rissanen, Kaija Laurila, Antti Reunanen and K. Mustalahti and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Olli Lohi

77 papers receiving 1.8k citations

Hit Papers

Increasing prevalence of ... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olli Lohi Finland 21 715 572 476 371 317 85 1.8k
Dror Berel United States 25 700 1.0× 105 0.2× 380 0.8× 388 1.0× 79 0.2× 53 1.9k
Hiroki Nakayama Japan 29 905 1.3× 103 0.2× 159 0.3× 334 0.9× 130 0.4× 111 2.5k
Anthony L. Guerrerio United States 16 672 0.9× 129 0.2× 187 0.4× 276 0.7× 49 0.2× 35 1.7k
Teresa S. Kim United States 22 648 0.9× 207 0.4× 203 0.4× 236 0.6× 67 0.2× 47 2.1k
Paola Braidotti Italy 25 496 0.7× 44 0.1× 260 0.5× 232 0.6× 152 0.5× 65 1.7k
Yuta Takahashi Japan 20 1.2k 1.6× 97 0.2× 229 0.5× 368 1.0× 52 0.2× 67 2.0k
Alfonso Martínez Spain 27 336 0.5× 145 0.3× 228 0.5× 214 0.6× 30 0.1× 74 1.8k
Laurence J. Meyer United States 24 870 1.2× 75 0.1× 346 0.7× 69 0.2× 270 0.9× 46 2.0k
Rosa Sorrentino Italy 31 626 0.9× 81 0.1× 429 0.9× 174 0.5× 46 0.1× 110 3.6k
Masazumi Takahashi Japan 27 435 0.6× 599 1.0× 73 0.2× 806 2.2× 32 0.1× 106 2.4k

Countries citing papers authored by Olli Lohi

Since Specialization
Citations

This map shows the geographic impact of Olli Lohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olli Lohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olli Lohi more than expected).

Fields of papers citing papers by Olli Lohi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olli Lohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olli Lohi. The network helps show where Olli Lohi may publish in the future.

Co-authorship network of co-authors of Olli Lohi

This figure shows the co-authorship network connecting the top 25 collaborators of Olli Lohi. A scholar is included among the top collaborators of Olli Lohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olli Lohi. Olli Lohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maqbool, Khurram, Roger Kramer, Hassan Foroughi Asl, et al.. (2025). Genomic determinants of therapy response in ETV6::RUNX1 leukemia. Leukemia. 39(9). 2125–2139.
2.
Lohi, Olli, Tuure Kinnunen, Markku Varjosalo, et al.. (2025). SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells. Oncogene. 44(18). 1259–1271.
3.
Rantapero, Tommi, Matti Nykter, Olli Lohi, et al.. (2023). Characterization of the innate immune response to Streptococcus pneumoniae infection in zebrafish. PLoS Genetics. 19(1). e1010586–e1010586. 6 indexed citations
4.
6.
Aine, Liisa, Mataleena Parikka, Sauli Palmu, et al.. (2020). Randomized controlled and double‐blinded study of Caphosol versus saline oral rinses in pediatric patients with cancer. Pediatric Blood & Cancer. 67(10). e28520–e28520. 8 indexed citations
7.
Pölönen, Petri, Juha Mehtonen, Jake Lin, et al.. (2019). Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies. Cancer Research. 79(10). 2466–2479. 19 indexed citations
8.
Arvela, H, et al.. (2019). Predicting residential radon concentrations in Finland: Model development, validation, and application to childhood leukemia. Scandinavian Journal of Work Environment & Health. 46(3). 278–292. 23 indexed citations
9.
Talibov, Madar, Ann Olsson, Helen D. Bailey, et al.. (2019). Parental occupational exposure to low-frequency magnetic fields and risk of leukaemia in the offspring: findings from the Childhood Leukaemia International Consortium (CLIC). Occupational and Environmental Medicine. 76(10). 746–753. 11 indexed citations
10.
Bock, Charles E. de, Sofie Demeyer, Sandrine Degryse, et al.. (2018). HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development. Cancer Discovery. 8(5). 616–631. 70 indexed citations
11.
Wolthers, Benjamin Ole, P. Mogensen, Thomas Leth Frandsen, et al.. (2018). Insulin‐dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 66(1). e27437–e27437. 9 indexed citations
12.
Nordfors, Kristiina, Joonas Haapasalo, Ebrahim Afyounian, et al.. (2018). Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma. Molecular Case Studies. 4(2). a002246–a002246. 6 indexed citations
13.
Raitanen, Jani, et al.. (2016). Residential mobility and the risk of childhood leukemia. Cancer Causes & Control. 27(3). 433–443. 6 indexed citations
14.
Lindfors, Katri, Ilma R. Korponay‐Szabó, Olli Lohi, et al.. (2008). Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits. BMC Immunology. 9(1). 6–6. 26 indexed citations
15.
Mustalahti, K., Katri Kaukinen, Kaija Laurila, et al.. (2007). Increasing prevalence of coeliac disease over time. Alimentary Pharmacology & Therapeutics. 26(9). 1217–1225. 571 indexed citations breakdown →
16.
Lohi, Olli. (2004). Diverse Substrate Recognition Mechanisms for Rhomboids Thrombomodulin Is Cleaved by Mammalian Rhomboids. Current Biology. 14(3). 236–241. 31 indexed citations
17.
Lohi, Olli, Anssi Poussu, Yuxin Mao, Florante A. Quiocho, & Veli-Pekka Lehto. (2001). VHS domain – a longshoreman of vesicle lines. FEBS Letters. 513(1). 19–23. 57 indexed citations
18.
Lohi, Olli & Veli‐Pekka Lehto. (1998). VHS domain marks a group of proteins involved in endocytosis and vesicular trafficking. FEBS Letters. 440(3). 255–257. 62 indexed citations
19.
Lohi, Olli & Veli-Pekka Lehto. (1998). Src phosphorylates EAST, a novel EGF receptor‐associated protein. FEBS Letters. 432(3). 225–227. 5 indexed citations
20.
Lohi, Olli & V.-P. Lehto. (1998). ITAM motif in an apoptosis-receptor. APOPTOSIS. 3(5). 335–336. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026